by Hui Xu, Mark S. Williams, and Lisa M. Spain

Slides:



Advertisements
Similar presentations
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes.
Advertisements

Darren M Brown, Erkki Ruoslahti  Cancer Cell 
Arterioscler Thromb Vasc Biol
MHC class II/CD38/CD9: a lipid-raft–dependent signaling complex in human monocytes by Marie-Thérèse Zilber, Niclas Setterblad, Thierry Vasselon, Christelle.
Overexpression of suppressor of cytokine signaling-1 impairs pre-T-cell receptor–induced proliferation but not differentiation of immature thymocytes by.
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells by Weiqing.
Volume 9, Issue 5, Pages (November 1998)
Upregulation of Cortactin Expression During the Maturation of Megakaryocytes by Xi Zhan, Christian C. Haudenschild, Yangson Ni, Elizabeth Smith, and Cai.
Activation of JAK2 in Human Vascular Endothelial Cells by Granulocyte-Macrophage Colony-Stimulating Factor by Raffaella Soldi, Luca Primo, Maria Felice.
by Mineo Iwata, Lynn Graf, Norihiro Awaya, and Beverly Torok-Storb
Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9 by Miguel Angel de la Fuente, Victoria.
FOG-1 represses GATA-1-dependent FcϵRI β-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice by Keiko Maeda, Chiharu.
Differentiation of CD4+ T Cells to Th1 Cells Requires MAP Kinase JNK2
CD74 induces TAp63 expression leading to B-cell survival
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer by Ou Cao, Eric Dobrzynski,
Skin-Specific Expression of ank-393, a Novel Ankyrin-3 Splice Variant
Volume 26, Issue 3, Pages (March 2007)
Galectin-5 is bound onto the surface of rat reticulocyte exosomes and modulates vesicle uptake by macrophages by Céline Barrès, Lionel Blanc, Pascale Bette-Bobillo,
by Silke Huber, Reinhard Hoffmann, Femke Muskens, and David Voehringer
by Alexander Kiani, Francisco J
Inhibition of Th1 Differentiation by IL-6 Is Mediated by SOCS1
by Xiaowu Zhang, and Ruibao Ren
Xiao-Feng Yang, Georg F Weber, Harvey Cantor  Immunity 
by Mi-Ae Kang, Su-Young Yun, and Jonghwa Won
by Guang Yang, Shu-Ching Huang, Jane Y. Wu, and Edward J. Benz
by Shrikanth P. Hegde, JingFeng Zhao, Richard A. Ashmun, and Linda H
by Subburaj Ilangumaran, Anne Briol, and Daniel C. Hoessli
Detection of Protein Tyrosine-Kinase (PTK) Gene Expression Pattern in Normal and Malignant T Lymphocytes by Combined PTK-Specific Polymerase Chain Reaction.
LPS induces CD40 gene expression through the activation of NF-κB and STAT-1α in macrophages and microglia by Hongwei Qin, Cynthia A. Wilson, Sun Jung Lee,
Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis
by Ulrike Schleicher, Andrea Hesse, and Christian Bogdan
Lineage-Restricted Expression of Protein Kinase C Isoforms in Hematopoiesis by Alessandra Bassini, Giorgio Zauli, Giovanni Migliaccio, Anna Rita Migliaccio,
Durbaka V.R Prasad, Sabrina Richards, Xoi Muoi Mai, Chen Dong  Immunity 
Elias T. Spiliotis, Manuel Osorio, Martha C. Zúñiga, Michael Edidin 
Volume 18, Issue 4, Pages (April 2003)
Volume 15, Issue 6, Pages (December 2001)
Fyn Can Partially Substitute for Lck in T Lymphocyte Development
Differential Roles of ERK and p38 MAP Kinase Pathways in Positive and Negative Selection of T Lymphocytes  Takehiko Sugawara, Tetsuo Moriguchi, Eisuke.
Volume 34, Issue 1, Pages (January 2011)
Darren M Brown, Erkki Ruoslahti  Cancer Cell 
Volume 27, Issue 1, Pages (July 2007)
Volume 25, Issue 5, Pages (November 2006)
Christopher L. Kepley, PhDa, John C. Cambier, PhDb, Penelope A
Ludovica Bruno, Hans Jörg Fehling, Harald von Boehmer  Immunity 
Volume 6, Issue 3, Pages (March 1997)
Volume 9, Issue 5, Pages (November 1998)
Ly6d-L, a Cell Surface Ligand for Mouse Ly6d
Volume 12, Issue 5, Pages (May 2000)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
CTLA-4 Regulates Induction of Anergy In Vivo
Volume 15, Issue 2, Pages (August 2001)
B7h, a Novel Costimulatory Homolog of B7. 1 and B7
Volume 7, Issue 2, Pages (August 1997)
Rodney P. DeKoter, Hyun-Jun Lee, Harinder Singh  Immunity 
Expression of FcRn, the MHC Class I-Related Receptor for IgG, in Human Keratinocytes  Karla Cauza, Gabriele Hinterhuber, Ruth Dingelmaier-Hovorka, Karin.
Anu Cherukuri, Paul C. Cheng, Hae Won Sohn, Susan K. Pierce  Immunity 
Volume 35, Issue 4, Pages (October 2011)
Volume 16, Issue 2, Pages (February 2002)
Negative Selection at the Pre-BCR Checkpoint Elicited by Human μ Heavy Chains with Unusual CDR3 Regions  Yoshiyuki Minegishi, Mary Ellen Conley  Immunity 
Notch 1 Signaling Regulates Peripheral T Cell Activation
Volume 15, Issue 5, Pages (November 2001)
Volume 4, Issue 4, Pages (October 1999)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
RORγt, a Novel Isoform of an Orphan Receptor, Negatively Regulates Fas Ligand Expression and IL-2 Production in T Cells  You-Wen He, Michael L Deftos,
Volume 28, Issue 1, Pages (January 2008)
Elias T. Spiliotis, Manuel Osorio, Martha C. Zúñiga, Michael Edidin 
Volume 23, Issue 2, Pages (August 2005)
Volume 19, Issue 4, Pages (October 2003)
Activation of the Lck Tyrosine Kinase Targets Cell Surface T Cell Antigen Receptors for Lysosomal Degradation  Ugo D'Oro, Melanie S Vacchio, Allan M Weissman,
Presentation transcript:

by Hui Xu, Mark S. Williams, and Lisa M. Spain Patterns of expression, membrane localization, and effects of ectopic expression suggest a function for MS4a4B, a CD20 homolog in Th1 T cells by Hui Xu, Mark S. Williams, and Lisa M. Spain Blood Volume 107(6):2400-2408 March 15, 2006 ©2006 by American Society of Hematology

MS4a4B mRNA is expressed in mouse tissues and cells. MS4a4B mRNA is expressed in mouse tissues and cells. (A) Northern blot: 10 μg RNA was separated on 1% denatured agarose gel and transferred to membrane, probed using Ms4a4b or G3PDH probes, washed, and exposed overnight. The length of the transcript is shown. (B) RT-PCR: samples were normalized by HPRT PCR and then were amplified with the primers specific for Ms4a4b, separated by gel, stained with ethidium bromide, and photographed. Samples were IL-2-expanded NK cells from severe combined immunodeficient (SCID) bone marrow, WEHI-231 B cells, Mel-201 erythroid line, J774 macrophage line, and 70Z-13 pre-B-cell line. (C) Quantitative PCR for expression of Ms4a4b, Ms4a4c, and Ms4a4d was performed using the Light-Cycler system (see “Materials and methods”). Results are in arbitrary units normalized to HPRT, and ribosomal RNA standards were done in parallel. Results shown are representative of 2 experiments. Samples are (1) expanded primary NK cells, (2) bone marrow, (3) whole spleen, (4) kidney, (5) pre-B-cell line 70Z13, (6) brain, (7) liver, (8) lung, (9) macrophage line (J774) FACS-sorted cells, (10) CD4 SP (single-positive thymocytes), (11) spleen T cells (CD3+), (12) spleen NK cells (NK1.1+), and (13) macrophages (Mac1+). (D) Alignments of deduced amino acid sequences for the mouse Ms4a4 subfamily, Ms4a1 (CD20), and Ms4a2 (FcϵRIβ). The membrane-spanning domains (TM) are predicted by TMHMM 2.0 program and underlined. Identical sequences are indicated by bold letters in light shade; conservative sequences by unshaded letters; nonhomologous sequences by dark shade. ITAM motif in cytoplasmic domain of MS4a2 is indicated as italic. Hui Xu et al. Blood 2006;107:2400-2408 ©2006 by American Society of Hematology

Anti-MS4a4B antibody recognizes both native and retrovirus-expressed MS4a4B. Anti-MS4a4B antibody recognizes both native and retrovirus-expressed MS4a4B. (A) Western blot of MS4a4B in tissues. Tissue samples from mouse liver, spleen, and thymus were lysed, blotted, and probed with rabbit anti-MS4a4B antibody. Blots were stripped and reprobed with anti-β-actin as a loading control. The position of MS4a4B is shown with an apparent MW of 24 kDa. (B) Lysates from thymus were immunoprecipitated by anti-MS4a4B antibody (or rabbit Ig control)-coated Protein A-Sepharose 4B. The bound proteins were eluted and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted by anti-MS4a4B antibody as described under “Materials and methods.” Expected positions of MS4a4B protein and Ig light chain are shown. The lanes are as follows: (1) total spleen protein (no immunoprecipitation), (2) IP with MS4a4B, (3) IP with control rabbit IgG, (4) MS4a4B IP blocked with MS4a4B immunizing peptide, (5) MS4a4B IP blocked with control MCC peptide. (C) NIH 3T3 cells were infected by MS4a4B retroviral vector or MIGR (empty vector) control. Staining and flow cytometry were performed as described in “Materials and methods.” The results are shown as fluorescence intensity of MS4a4B (solid heavy line) or rabbit IgG control (light line, shaded) in gated GFP+ populations. Results shown are representative of 2 experiments. Hui Xu et al. Blood 2006;107:2400-2408 ©2006 by American Society of Hematology

MS4a4B protein is expressed in thymocytes. MS4a4B protein is expressed in thymocytes. (A) Double-negative thymocytes were analyzed by flow cytometry using 4-color staining. The samples were gated first on the CD4/CD8 double-negative population and subsequently on the 4 subsets of CD44 and CD25 expression, and then analyzed for MS4a4B as shown. Fluorescence intensity of MS4a4B (solid heavy line) or rabbit IgG control (light line) in each selected subset. (B) Total thymocytes were analyzed by flow cytometry as described in “Materials and methods” using 3-color staining. CD4 and CD8 were used for gating thymocyte subpopulations, and anti-MS4a4B (bold line) or Ig as control (light line) was analyzed subsequently as shown. Results shown are representative of 2 separate experiments. Hui Xu et al. Blood 2006;107:2400-2408 ©2006 by American Society of Hematology

MS4a4B protein is detected by FACS analysis. MS4a4B protein is detected by FACS analysis. Cells were isolated, stained for surface markers where indicated, fixed and permeabilized, and stained with anti-MS4a4B (solid line) or rabbit Ig (light line with shading) as control. (A) Spleen cells stained for the indicated lineage markers. (B) Staining results for T-cell clones (5cc7, T32, AE7, CTLL-2, HT-2) and hybridomas (58α and α28) are shown. (C) Staining results for Mac1+ cells, freshly isolated from spleen, analyzed immediately (fresh), or expanded in vitro with MCSF (expanded) for 7 days before analysis. Results shown are representative of 3 separate experiments. Hui Xu et al. Blood 2006;107:2400-2408 ©2006 by American Society of Hematology

MS4a4B is expressed on the cell surface. MS4a4B is expressed on the cell surface. NIH 3T3 cells or 58α T-hybridoma cells were infected with retrovirus encoding MS4a4B with an extracellular HA epitope tag or with an MIGR vector control. Viral transduction was detected by expression of green fluorescent protein (GFP). Cells were stained with anti-HA mAb and analyzed by flow cytometry. The inset numbers represent the percent of viable (propidium iodide-negative) cells in each quadrant. Results shown are representative of at least 5 separate experiments. Hui Xu et al. Blood 2006;107:2400-2408 ©2006 by American Society of Hematology

MS4a4B is located in lipid rafts. MS4a4B is located in lipid rafts. (A-F) T-hybridoma cells expressing the MS4a4B-HA tag were stained with antibodies before FACS analysis as indicated. (A) HA staining of cells untreated (bold line) or treated with Triton X-100 (TX; light line) compared with control vector-infected cells (dashed line). (B) TCR staining of cells untreated (bold line) or TX treated (light line). (C) Thy-1-stained cells untreated (bold line) or TX treated (light line). (D) HA staining for cells untreated (dash line), treated with TX (light line), treated with 10 mM MbCD (bold line), treated with 10 mM MbCD and subsequently TX (shaded line). (E) Thy-1 staining of cells treated as in panel G (MbCD alone not shown). (F) HA staining of cells untreated (dashed line) or treated with sphingomyelinase, 5 U/mL (light line), 10 U/mL (shaded line). (G-H) MS4a4B translocates to lipid rafts in activated spleen cells. Spleen cells were cultured for the indicated times in the presence or absence of concanavalin A (ConA). Cells lysates were separated on discontinuous sucrose gradients, fractionated and selected raft (R) and non-raft (N) fractions were pooled (G), or all fractions were analyzed separately (H). A corresponding amount of the total lysate was reserved before fractionation for comparative purposes (T). Fractions were separated by PAGE and immunoblotted with antibodies to MS4a4B, LAT, or transferrin receptor (CD71) or blotted with labeled cholera toxin B (to detect raft glycoprotein GM1). Results shown are representative of 3 separate experiments. Hui Xu et al. Blood 2006;107:2400-2408 ©2006 by American Society of Hematology

MS4a4B augments IL-2 production from stimulated T cells. MS4a4B augments IL-2 production from stimulated T cells. (A) T-cell hybridoma cells (α3A3) were infected with retrovirus encoding MS4a4B or with an MIGR vector control. GFP+ infected cells were FACS sorted and stimulated with graded amounts of antigen (moth cytochrome C [MCC] peptide) presented by antigen-presenting cells (APCs). Supernatants were harvested after 24 hours, and IL-2 production was measured by CTLL-2 bioassay. The data are representative of 4 independent experiments, and points are averages and SDs of quadruplicate wells. (B) Primary CD4+ mouse T-cell blasts were infected with retrovirus-encoding MS4a4B or with a MIGR vector control. Cells were restimulated with PMA and ionomycin in the presence of monensin for 4 hours, and cytokine production was determined by intracellular cytokine staining in GFP+ cells using flow cytometry. The data represent the percentage of GFP+ cells that were cytokine positive. The results shown are the averages plus SE of 4 separate experiments. *Significantly different from vector control (P < .05). Hui Xu et al. Blood 2006;107:2400-2408 ©2006 by American Society of Hematology